CRP and systemic lupus erythematosus: Studies in the context of autoinflammatory diseases such as RA, SLE, UC, and CD have proposed MDK as a marker for the detection of inflammatory disease activity (92, 93, 128, 129), with a performance comparable to, and potentially superior to established disease activity markers like C-reactive protein (CRP) (92, 93).